Home Enceladus

Enceladus

In operation
Seed Round Financing
Drug developers aimed at finding innovative combinations of existing drugs and drug delivery systems
Basic
Enterprise Profile

Basic Information

Enceladus's drug contains an anti-inflammatory corticosteroid that selectively targets the actual pathological sites of inflammatory diseases, enabling users to receive sub-tissue formulations of corticosteroids for treating inflammation, autoimmune diseases, and cancer.
Enceladus
NorthHolland,Netherlands
less than 15 people
January 01, 2005
info@enceladus.nl

Enterprise Profile

Technology
Targeted Technology
Concept
Immune System Diseases